Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study.

× No keyword cloud information.

9 in total

1. FURTHER EXPERIENCE OF ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION TO SINUS RHYTHM: ANALYSIS OF 100 PATIENTS.

Authors: S ORAM; J P DAVIES
Journal: Lancet Date: 1964-06-13 Impact factor: 79.321

2. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation.

Authors: C J Bjerkelund; O M Orning
Journal: Am J Cardiol Date: 1969-02 Impact factor: 2.778

3. Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate.

Authors: E Byrne-Quinn; A J Wing
Journal: Br Heart J Date: 1970-05

4. Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine.

Authors: J I Hall; D R Wood
Journal: Br Heart J Date: 1968-01

5. An evaluation of DC shock treatment of atrial arrhythmias.

Authors: C Bjerkelund; O M Orning
Journal: Acta Med Scand Date: 1968-12

6. Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation.

Authors: G Härtel; A Louhija; A Konttinen; P I Halonen
Journal: Br Heart J Date: 1970-01

7. Electrical reversion of cardiac arrhythmias.

Authors: B Lown
Journal: Br Heart J Date: 1967-07

8. Direct current conversion of atrial fibrillation.

Authors: P B Halmos
Journal: Br Heart J Date: 1966-05

9. Direct current shock therapy of cardiac arrhythmias.

Authors: P Szekely; G A Batson; D C Stark
Journal: Br Heart J Date: 1966-05

9 in total

12 in total

Review 1. Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors: S Nattel
Journal: Drugs Date: 1991-05 Impact factor: 9.546

2. Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.

Authors: G M Frigo; E Perucca; M Teggia-Droghi; G Gatti; A Mussini; J Salerno
Journal: Br J Clin Pharmacol Date: 1977-08 Impact factor: 4.335

3. [Drug therapy of tachyarrhythmias (author's transl)].

Authors: K Theisen
Journal: Klin Wochenschr Date: 1978-02-15

4. Serum quinidine levels after administration of three different quinidine preparations.

Authors: R Henning; G Nyberg
Journal: Eur J Clin Pharmacol Date: 1973-12 Impact factor: 2.953

5. The drug treatment of atrial fibrillation.

Authors: K S Channer
Journal: Br J Clin Pharmacol Date: 1991-09 Impact factor: 4.335

6. Short-acting and long-acting quinidine for maintenance of sinus rhythm after electrical conversion.

Authors:
Journal: Br Heart J Date: 1977-02

Review 7. Adverse effects of antiarrhythmic drugs.

Authors: J B Schwartz; D Keefe; D C Harrison
Journal: Drugs Date: 1981-01 Impact factor: 9.546

8. Evidence at a glance: error matrix approach for overviewing available evidence.

Authors: Frederik Keus; Jørn Wetterslev; Christian Gluud; Cornelis J H M van Laarhoven
Journal: BMC Med Res Methodol Date: 2010-10-01 Impact factor: 4.615

9. Determinants of recurrent atrial flutter after cardioversion.

Authors: R G Pozen; J Pastoriza; J J Rozanski; K M Kessler; R J Myerburg
Journal: Br Heart J Date: 1983-07

10. Quinidine for pharmacological cardioversion of atrial fibrillation: a retrospective analysis in 501 consecutive patients.

Authors: Bernhard Schwaab; Alexander Katalinic; Uta Maria Böge; Jürgen Loh; Peter Blank; Tatjana Kölzow; Dirk Poppe; Hendrik Bonnemeier
Journal: Ann Noninvasive Electrocardiol Date: 2009-04 Impact factor: 1.468